🇺🇸 FDA
Patent

US 8999336

Monoclonal antibodies against Orthopoxviruses

granted A61KA61K2039/505A61K2039/545

Quick answer

US patent 8999336 (Monoclonal antibodies against Orthopoxviruses) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/505, A61K2039/545, A61K39/00, A61P